Back to top
more

IQVIA (IQV)

(Delayed Data from NYSE)

$239.67 USD

239.67
1,195,238

+7.38 (3.18%)

Updated Jul 26, 2024 04:00 PM ET

After-Market: $239.72 +0.05 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

IQVIA Holdings (IQV) Q3 Earnings Top Estimates, Revenues Miss

IQVIA Holdings' (IQV) revenues increase year over year in third-quarter 2023.

IQVIA Holdings (IQV) Q3 Earnings Surpass Estimates

IQVIA (IQV) delivered earnings and revenue surprises of 1.22% and 1.21%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Shockwave Medical (SWAV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Shockwave Medical (SWAV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why IQVIA (IQV) is Poised to Beat Earnings Estimates Again

IQVIA (IQV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

IQVIA (IQV) to Report Q3 Earnings: What's in the Offing?

IQVIA's (IQV) revenues are likely to increase year over year on the back of improving segmental performance.

IQVIA Holdings (IQV) Expected to Beat Earnings Estimates: Should You Buy?

IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for West Pharmaceutical (WST) in Q3 Earnings?

West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.

Indrajit Bandyopadhyay headshot

4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates

Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.

Intuitive Surgical (ISRG) to Post Q3 Earnings: What's in Store?

Intuitive Surgical's (ISRG) third-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.

IQVIA (IQV) and argenx Partner to Advance Autoimmune Care

IQVIA (IQV) and argenx expand collaboration to advance rare autoimmune treatments through innovative pharmacovigilance.

Here's Why Investors Should Retain IQVIA (IQV) Stock Now

An addressable market size and strong healthcare-specific global IT infrastructure boost IQVIA (IQV).

IQVIA (IQV) Up 2.5% Since Last Earnings Report: Can It Continue?

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IQVIA (IQV) Stock Improves 8% in Three Months: Here's How

IQVIA (IQV) aims at market expansion through innovation and service improvements.

IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y

IQVIA Holdings (IQV) second-quarter 2023 revenues improve year over year.

IQVIA (IQV) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

IQVIA Holdings (IQV) Surpasses Q2 Earnings and Revenue Estimates

IQVIA (IQV) delivered earnings and revenue surprises of 2.53% and 0.66%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Soumyadeep Bose headshot

Business Services' Q2 Earnings Lineup on Aug 1: IT, IQV & NSP

Investors interested in the Business Services sector can watch earnings reports of IT, IQV and NSP to be released on Aug 1.

IQVIA (IQV) to Report Q2 Earnings: What's in the Offing?

IQVIA's (IQV) revenues are likely to increase year over year on the back of improving segmental performance.

Coursera (COUR) Reports Break-Even Earnings for Q2

Coursera (COUR) delivered earnings and revenue surprises of 100% and 5.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Thomson Reuters (TRI) Earnings Expected to Grow: Should You Buy?

Thomson Reuters (TRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate IQVIA Holdings (IQV) to Report a Decline in Earnings: What to Look Out for

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 Stocks to Watch From a Promising Technology Services Industry

The Zacks Technology Services industry seeks to benefit from the increased dependency on technology, digitization and the growing adoption of the multi-cloud model. TT, IQV and APTV are well poised to witness a demand surge.

IQVIA (IQV) Stock Gains 10% in Three Months: Here's How

IQVIA (IQV) aims at market expansion through innovation and service improvements.

Ethan Feller headshot

Stanley Druckenmiller is Bullish on AI, these are His Top 3 Stock Picks

Druckenmiller note, AI companies could have very strong earnings even in the face of an economic downturn

Why You Should Retain IQVIA Holdings (IQV) Stock for Now

IQVIA Holdings' (IQV) enormous treasure trove of information is a distinguishing asset and also perhaps a big barrier to entry for competitors.